How Well Do You Know Hybrid?
Keep your finger on the pulse of open access with the most important conversations taking place this year on the topic of hybrid OA.
International Copyright News Must-Reads: Summer 2018
In a few minutes, catch up on vital international copyright legislation and court case news from Europe, Australia and Canada.
Publishing’s Gender Pay Gap
The digital revolution that gave rise to independent publishing in the last decade has even replicated the traditional segregation and discrimination.
Digital Transformation Accelerators for Content Reuse
Forward-thinking editors demand freedom to reuse and repurpose content in innovative, high value ways, especially on mobile devices.
Why Open Access Publishing is Growing in Latin America
Latin American researchers have a specific social commitment to ensure that their work is accessible and contributing to the good of their communities.
How the FDA Plans to Modernize New Drugs Review Process
The FDA wants to empower the agency’s scientists and medical officers to take on more “thought leadership.” Here’s how they plan to do it.
18 Inspiring Tweets from #SLA2018
Couldn’t attend Special Libraries Association’s annual conference in Baltimore this year? Have no fear – we’ve rounded up some of our favorite bite-sized tips, session snippets and inspiration from the show:
How to Achieve Digital Dexterity: 4 Elements of Focus
Most large companies are not known for being nimble and agile. So how can these organizations develop the dexterity to compete in today’s digital age?
Blockchain for Science: Part One – A Primer
Joris van Rossum, Director of Special Projects at Digital Science, shares his views on the ways blockchain could be a game changer in the ecosystem of scholarly publishing.
3 Takeaways for Pharma Orgs from President Trump’s ‘American Patients First’ Speech
Analysts can’t decide whether the “American Patients First” program will serve U.S. consumers well in the long run, but most agreed that the administration is right in attempting to tackle the complex and important issue of drug prices.